Taiko Pharmaceutical Co.,Ltd. provided earnings guidance for the year ending December 2024. For the year, the company expects net sales of ¥6,800 million, operating profit of ¥410 million, profit attributable to owners of parent of ¥350 million and basic earnings per share of ¥6.98.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
376 JPY | +1.08% | -1.57% | +24.09% |
1st Jan change | Capi. | |
---|---|---|
+24.09% | 120M | |
+18.04% | 42.95B | |
+16.92% | 21.38B | |
+18.33% | 15.05B | |
+19.27% | 14.45B | |
+56.12% | 13.04B | |
-0.05% | 6.79B | |
-10.73% | 6.72B | |
-8.87% | 5.73B | |
+11.21% | 5.47B |
- Stock Market
- Equities
- 4574 Stock
- News Taiko Pharmaceutical Co.,Ltd.
- Taiko Pharmaceutical Co.,Ltd. Provides Earnings Guidance for the Year Ending December 2024